jeudi 8 septembre 2022

FDA Approves Daxxify, a New Anti-Wrinkle Drug

The treatment lasts for six months in half of its users, company studies showed, representing the first major advance in facial injections in decades.

from NYT > Health https://ift.tt/IMKBE9W
via health&fitness

Aucun commentaire:

Enregistrer un commentaire